Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with a type of pancreatic cancer called pancreatic ductal adenocarcinoma, confirmed by a biopsy or medical imaging scan
- You are 18 years of age or older (any gender)
- You are currently receiving a treatment that includes a medication called irinotecan hydrochloride liposome injection II
- You are willing to take part in the study and are able to sign a consent form agreeing to participate
Who may not be able to join:
- Women who are confirmed to be pregnant or currently breastfeeding
- People whose doctors feel there are other reasons they would not be suitable for this study (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Taiping Zhang, doctor, Peking Union Medical College Hospital, Beijing, China
Phone: +86 13520132976
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
rwTEAE
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.